Nissin Foods Wins Bid for Acquiring Equity Interest in Zhuhai Winner at RMB352.44 Million 5 bulan ago
China Risun’s 2022 Interim Revenue Ups 21.1% to RMB22.53 Billion, Profit Attributable to Owners was RMB1.74 Billion 7 bulan ago
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion 7 bulan ago
EC Healthcare Included in the Hang Seng Composite Index & Hang Seng Stock Connect Hong Kong Index 1 tahun ago
Shareholders and senior management show confidence in China Risun by increasing stakes recently 1 tahun ago
Sino Biopharmaceutical Donates Cash and Supplies Valued at RMB10 Million to Support Henan for Flood Relief and Preventing Epidemic 2 tahun ago
China Risun Establish a Joint Venture to Invest In and Construct a Coking Project with an Annual Volume of 4.7 Million Tonnes in Indonesia 2 tahun ago
Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion 2 tahun ago
